Moderna Correlations

MRNA Stock  USD 32.17  1.31  4.24%   
The current 90-days correlation between Moderna and Bio Techne Corp is 0.24 (i.e., Modest diversification). The correlation of Moderna is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Moderna Correlation With Market

Very weak diversification

The correlation between Moderna and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.

Moving together with Moderna Stock

  0.62JPM JPMorgan ChasePairCorr

Moving against Moderna Stock

  0.42PG Procter GamblePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BBIORVMD
RVMDMDGL
JAZZMDGL
BBIOMDGL
MDGLEXEL
BBIORNA
  

High negative correlations

RNACAI
CAIMDGL
RVMDCAI
JAZZCAI
BBIOCAI
CAIEXEL

Risk-Adjusted Indicators

There is a big difference between Moderna Stock performing well and Moderna Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Moderna's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TECH  1.74  0.05  0.04  0.09  1.70 
 3.72 
 12.12 
BMRN  1.50  0.11  0.07  0.17  1.43 
 3.20 
 20.77 
EXEL  1.71  0.06  0.02  0.12  2.52 
 4.27 
 14.78 
MDGL  2.01  0.37  0.22  0.47  1.33 
 7.29 
 12.14 
CAI  2.35 (0.17) 0.00 (0.15) 0.00 
 4.40 
 22.72 
RNA  1.96  0.80  0.59  0.69  0.23 
 4.86 
 42.94 
RVMD  1.62  0.76  0.60  0.94  0.61 
 4.34 
 11.71 
JAZZ  1.55  0.48  0.25 (0.77) 1.17 
 3.66 
 24.53 
HALO  1.45 (0.08) 0.00 (0.14) 0.00 
 3.12 
 9.83 
BBIO  1.82  0.57  0.34  0.46  1.37 
 4.23 
 22.02 

Moderna Corporate Management

Melanie MBAChief OfficerProfile
Stephane BancelCEO DirectorProfile
Dave JohnsonChief OfficerProfile
Lavina CFASenior RelationsProfile
Noubar AfeyanIndependent CoFounderProfile
Allison MDSenior DevelopmentProfile